Johnson & Johnson Just Took $7 Billion in Charges and Still Raised Its Outlook. Here's What That Tells Investors.

Johnson & Johnson took a $7 billion charge in Q3 2026 due to talc litigation settlement ($5.5 billion) and strategic investments in acquisitions and partnerships. Despite a 96% decline in GAAP earnings per share, the company raised its full-year guidance and reported nearly 6% revenue growth, demonstrating the resilience of its core business and reinforcing its status as a Dividend King with 64 consecutive years of dividend increases.